Inhibition of CXCR4 by LY2624587, a Fully Humanized Anti-Cxcr4 Antibody Induces Apoptosis of Hematologic Malignancies

PLoS ONE - United States
doi 10.1371/journal.pone.0150585
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Therapeutic Potential of AO-176, a Next Generation Humanized CD47 Antibody, for Hematologic Malignancies

Blood
BiochemistryImmunologyCell BiologyHematology
2018English

Inhibition of the CXCL12/CXCR4 Chemokine Axis With AMD3100, a CXCR4 Small Molecule Inhibitor, Worsens Murine Hepatic Injury

Hepatology Research
HepatologyInfectious Diseases
2014English

A Humanized Anti-Human Fas Antibody, R-125224, Induces Apoptosis in Type I Activated Lymphocytes but Not in Type II Cells

International Immunology
MedicineAllergyImmunology
2005English

Hematologic Malignancies

Oncologist
Cancer ResearchMedicineOncology
1999English

The Structure of a CXCR4:Chemokine Complex

Frontiers in Immunology
AllergyImmunology
2015English

Sequential Tyrosine Sulfation of CXCR4 by Tyrosylprotein Sulfotransferases†

Biochemistry
Biochemistry
2008English

The Role of CXCR4 and Arrestins in Breast Cancer Signaling and Apoptosis

2006English

EPI-X4, a Novel Endogenous Antagonist of CXCR4

Oncotarget
Oncology
2015English

Targeting CXCR4-induced Desmoplasia to Improve Checkpoint Inhibition in Breast Cancer

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy